Does pre-existing respiratory disease affect 3-month outcome following COVID hospitalisation across 4 waves: A prospective cohort analysis
-
Published:2024-11
Issue:
Volume:86
Page:101110
-
ISSN:2590-0412
-
Container-title:Respiratory Medicine and Research
-
language:en
-
Short-container-title:Respiratory Medicine and Research
Author:
Vandekerckhove OliviaORCID,
Claeys Eveline,
Steyaert Nele,
De Wever Walter,
Godinas Laurent,
Janssens Wim,
Dupont Lieven,
Van Bleyenbergh Pascal,
Hermans Greet,
Lorent Natalie
Reference12 articles.
1. Virus-induced exacerbations in asthma and COPD;Kurai;Front Microbiol,2013
2. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study;Aveyard;Lancet Respir Med,2021
3. X. Wu, X. Liu, Y. Zhou, H. Yu, R. Li, Q. Zhan et al., “3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study,” 2021, 10.1016/S2213-2600(21)00174-0.
4. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge;Lorent;ERJ Open Res,2022
5. One year overview and follow-up in a post-COVID consultation of critically ill patients;González;Front Med,2022